Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.

作者: Barry J. Maron , N. A. Mark Estes , Martin S. Maron , Adrian K. Almquist , Mark S. Link

DOI: 10.1161/01.CIR.0000072343.81530.75

关键词:

摘要: Case Report : A 20-year-old asymptomatic man was diagnosed with hypertrophic cardiomyopathy (HCM) after routine physical examination during which a systolic heart murmur detected. Echocardiography showed massive left ventricular (LV) hypertrophy septal thickness of 36 mm extending into the anterolateral wall (30 mm); outflow obstruction absent. Ambulatory (Holter) ECG 3 isolated premature contractions, and blood pressure response to exercise normal. Echocardiographic examinations in parents siblings were negative for HCM. Although 2 centers advised against an implantable cardioverter-defibrillator (ICD) based on presence only 1 risk factor sudden death (ie, extreme hypertrophy), prophylactic device recommended by third cardiac consultant. After uneventful 16-month period ICD neither detected nor treated arrhythmias, unprovoked episode fibrillation triggered defibrillation shock that immediately restored sinus rhythm (Figure 1). Figure 1. Primary prevention Continuous recording stored intracardiac electrogram from young LV (septal mm). The senses automatically delivers (arrow), restores normal rhythm. HCM is most common genetic cardiovascular disease, since its description 45 years ago, has been visible devastating consequence.1–5 Indeed, HCM cause people (including trained athletes).5 Such events usually occur previously healthy individuals without significant symptoms or as initial clinical manifestation thus generating considerable anxiety sense vulnerability among patients families.2–5 Identification high-risk efforts at represent important challenges HCM.6 The introduced 25 ago treatment strategy lethal tachyarrhythmias.7 …

参考文章(19)
Philip R. Reid, Morton M. Mower, Levi Watkins, Vincent L. Gott, James F. Schauble, Alois Langer, M. S. Heilman, Steve A. Kolenik, Robert E. Fischell, Myron L. Weisfeldt, M. Mirowski, Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human Beings New England Journal of Medicine. ,vol. 303, pp. 322- 324 ,(1980) , 10.1056/NEJM198008073030607
E. Douglas Wigle, Harry Rakowski, Brian P. Kimball, William G. Williams, Hypertrophic Cardiomyopathy Clinical Spectrum and Treatment Circulation. ,vol. 92, pp. 1680- 1692 ,(1995) , 10.1161/01.CIR.92.7.1680
Arthur J. Moss, Wojciech Zareba, W. Jackson Hall, Helmut Klein, David J. Wilber, David S. Cannom, James P. Daubert, Steven L. Higgins, Mary W. Brown, Mark L. Andrews, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine. ,vol. 346, pp. 877- 883 ,(2002) , 10.1056/NEJMOA013474
Barry J. Maron, Sudden Death in Young Competitive Athletes JAMA. ,vol. 276, pp. 199- 204 ,(1996) , 10.1001/JAMA.1996.03540030033028
DENNIS W.X. ZHU, HUABIN SUN, RITA HILL, ROBERT ROBERTS, The Value of Electrophysiology Study and Prophylactic Implantation of Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy Pacing and Clinical Electrophysiology. ,vol. 21, pp. 299- 302 ,(1998) , 10.1111/J.1540-8159.1998.TB01109.X
Perry M Elliott, Juan R Gimeno Blanes, Niall G Mahon, Jan D Poloniecki, William J McKenna, Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. The Lancet. ,vol. 357, pp. 420- 424 ,(2001) , 10.1016/S0140-6736(00)04005-8
Eugene Braunwald, Christine E. Seidman, Ulrich Sigwart, Contemporary Evaluation and Management of Hypertrophic Cardiomyopathy Circulation. ,vol. 106, pp. 1312- 1316 ,(2002) , 10.1161/01.CIR.0000030314.11999.6A
Perry M Elliott, Jan Poloniecki, Shaughan Dickie, Sanjay Sharma, Lorenzo Monserrat, Amanda Varnava, Niall G Mahon, William J McKenna, Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. Journal of the American College of Cardiology. ,vol. 36, pp. 2212- 2218 ,(2000) , 10.1016/S0735-1097(00)01003-2
Barry J. Maron, Iacopo Olivotto, Paolo Spirito, Susan A. Casey, Pietro Bellone, Thomas E. Gohman, Kevin J. Graham, David A. Burton, Franco Cecchi, Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. ,vol. 102, pp. 858- 864 ,(2000) , 10.1161/01.CIR.102.8.858
Barry J. Maron, Hypertrophic cardiomyopathy: A Systematic review JAMA. ,vol. 287, pp. 1308- 1320 ,(2002) , 10.1001/JAMA.287.10.1308